Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid Arthritis

Lu Liu, Weisheng Guo, Xing-Jie Liang
  • Biotechnology Journal, September 2018, Wiley
  • DOI: 10.1002/biot.201800024

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Xing-Jie Liang

In partnership with: